Home / Companies / Bioverativ Therapeutics Inc / Wages
Bioverativ Therapeutics Inc H-1B wage rows
Compensation-first LCA rows for Bioverativ Therapeutics Inc, including offered wage, annualized wage, worksite, SOC code, fiscal year, QA flags, and source record evidence. Showing 50 returned rows using keyset pagination.
Summary
This view lists 50 H-1B LCA wage observations (more available via pagination).
Offered wages among the returned rows range from $54,163 to $221,000.
Employers in the returned rows include Bioverativ Therapeutics, Inc..
LCA filings are labor-condition applications certified by the U.S. Department of Labor, not active job postings or approved USCIS H-1B petitions.
Returned-page wage summary
| Scope | returned_page |
| Count | 50 |
| Annualized Min | 54,163 |
| Annualized P25 | 82,000 |
| Annualized Median | 100,000 |
| Annualized P75 | 116,896 |
| Annualized P90 | 132,454 |
| Annualized Max | 167,253 |
| Outlier Count | 0 |
| Role | Employer | SOC | Fiscal year | Worksite | Annualized offer | Spread | QA flags | Source |
|---|---|---|---|---|---|---|---|---|
| Clinical Supply Chain Project Leader I-200-26057-667372 | Bioverativ Therapeutics, Inc. | 11-3071.04 Supply Chain Managers | FY2026 Q2 | Waltham, MA, 02451 | $167,253 to $175,000 year | $0 | - | sr_dol_oflc_lca_2026_q2_row_039162 |
| Senior Associate Scientist, Research I-200-26026-589856 | Bioverativ Therapeutics, Inc. | 19-1021.00 Biochemists and Biophysicists | FY2026 Q2 | Cambridge, MA, 02141 | $79,581 to $122,500 year | $0 | - | sr_dol_oflc_lca_2026_q2_row_082735 |
| Scientist I-200-25261-319125 | Bioverativ Therapeutics, Inc. | 19-1021.00 Biochemists and Biophysicists | FY2025 Q4 | Cambridge, MA, 02141 | $101,026 to $140,000 year | $0 | - | sr_dol_oflc_lca_2025_q4_row_008012 |
| Scientist I-200-25133-970255 | Bioverativ Therapeutics, Inc. | 19-1042.00 Medical Scientists, Except Epidemiologists | FY2025 Q3 | Waltham, MA, 02451 | $104,416 to $140,000 year | $0 | - | sr_dol_oflc_lca_2025_q3_row_115632 |
| Clinical Supply Project Operational Leader I-200-23191-177763 | Bioverativ Therapeutics, Inc. | 11-3071.04 Supply Chain Managers | FY2023 Q4 | Waltham, MA, 02451 | $141,149 to $154,500 year | $0 | - | sr_dol_oflc_lca_2023_q4_row_112398 |
| Senior Associate Scientist, Rare Blood Disorders I-200-23138-033634 | Bioverativ Therapeutics, Inc. | 19-1021.00 Biochemists and Biophysicists | FY2023 Q3 | Cambridge, MA, 02141 | $93,150 to $113,575 year | $11,136 | - | sr_dol_oflc_lca_2023_q3_row_075851 |
| IT Lead I-200-23137-030289 | Bioverativ Therapeutics, Inc. | 15-1211.00 Computer Systems Analysts | FY2023 Q3 | Cambridge, MA, 02141 | $132,434 to $171,237 year | $0 | - | sr_dol_oflc_lca_2023_q3_row_077442 |
| Senior Associate Scientist, Rare Blood Disorders I-200-23137-030473 | Bioverativ Therapeutics, Inc. | 19-1021.00 Biochemists and Biophysicists | FY2023 Q3 | Cambridge, MA, 02141 | $93,150 to $113,575 year | $11,136 | - | sr_dol_oflc_lca_2023_q3_row_088247 |
| Senior Associate Scientist, Rare Blood Disorders I-200-23118-976133 | Bioverativ Therapeutics, Inc. | 19-1021.00 Biochemists and Biophysicists | FY2023 Q3 | Cambridge, MA, 02141 | $93,150 to $113,575 year | $11,136 | - | sr_dol_oflc_lca_2023_q3_row_100142 |
| Principal Scientist I-200-23011-694565 | Bioverativ Therapeutics, Inc. | 19-1042.00 Medical Scientists, Except Epidemiologists | FY2023 Q2 | Waltham, MA, 02451 | $143,686 to $193,593 year | $0 | - | sr_dol_oflc_lca_2023_q2_row_117814 |
| Scientist, Complement Research I-200-22348-640876 | Bioverativ Therapeutics, Inc. | 19-1021.00 Biochemists and Biophysicists | FY2023 Q1 | Cambridge, MA, 02141 | $108,410 to $127,500 year | $0 | - | sr_dol_oflc_lca_2023_q1_row_008320 |
| Scientist, Complement Research I-200-22348-640876 | Bioverativ Therapeutics, Inc. | 19-1021.00 Biochemists and Biophysicists | FY2023 Q2 | Cambridge, MA, 02141 | $108,410 to $127,500 year | $0 | - | sr_dol_oflc_lca_2023_q2_row_142920 |
| Senior Associate Scientist I-200-19350-200004 | Bioverativ Therapeutics, Inc. | 19-1021.00 Biochemists and Biophysicists | FY2022 Q4 | Waltham, MA, 2451 | $60,900 to $113,000 year | $434 | - | sr_dol_oflc_lca_2022_q4_row_026455 |
| Global Supply Network Planner & Analytics I-200-21139-324673 | Bioverativ Therapeutics, Inc. | 15-2031.00 Operations Research Analysts | FY2022 Q3 | Waltham, MA, 2451 | $63,000 to $117,000 year | $5,238 | - | sr_dol_oflc_lca_2022_q3_row_235430 |
| Scientist, Complement Research I-200-22158-252389 | Bioverativ Therapeutics, Inc. | 19-1021.00 Biochemists and Biophysicists | FY2022 Q3 | Cambridge, MA, 2141 | $84,448 to $127,500 year | $0 | - | sr_dol_oflc_lca_2022_q3_row_189465 |
| Associate Scientist I-200-19298-109045 | Bioverativ Therapeutics, Inc. | 19-1021.00 Biochemists and Biophysicists | FY2022 Q3 | Waltham, MA, 2451 | $82,930 to $113,100 year | $0 | - | sr_dol_oflc_lca_2022_q3_row_050384 |
| Associate Director Regulatory CMC I-200-20107-492785 | Bioverativ Therapeutics, Inc. | 11-9199.01 Regulatory Affairs Managers | FY2021 Q4 | Waltham, MA, 2451 | $159,744 to $221,000 year | $0 | - | sr_dol_oflc_lca_2021_q4_row_108408 |
| Global Study Manager I-200-20085-435212 | Bioverativ Therapeutics, Inc. | 15-2041.02 Clinical Data Managers | FY2021 Q4 | Waltham, MA, 2451 | $132,454 to $165,000 year | $0 | - | sr_dol_oflc_lca_2021_q4_row_013625 |
| Senior Associate Scientist I-200-21167-404314 | Bioverativ Therapeutics, Inc. | 19-1020.01 Biologists | FY2021 Q3 | Waltham, MA, 2451 | $82,000 to $117,000 year | $16,200 | - | sr_dol_oflc_lca_2021_q3_row_391195 |
| Global Supply Network Planner & Analytics I-200-21139-324673 | Bioverativ Therapeutics, Inc. | 15-2031.00 Operations Research Analysts | FY2021 Q3 | Waltham, MA, 2451 | $63,000 to $117,000 year | $5,238 | - | sr_dol_oflc_lca_2021_q3_row_326320 |
| Senior Associate, Statistical Programming I-200-20346-954124 | Bioverativ Therapeutics, Inc. | 15-2041.00 Statisticians | FY2021 Q2 | Waltham, MA, 02451 | $116,896 to $127,500 year | $39,312 | - | sr_dol_oflc_lca_2021_q2_row_047431 |
| Senior Associate, Statistical Programming I-200-20346-954124 | Bioverativ Therapeutics, Inc. | 15-2041.00 Statisticians | FY2021 Q3 | Waltham, MA, 2451 | $116,896 to $127,500 year | $39,312 | - | sr_dol_oflc_lca_2021_q3_row_165393 |
| Senior Specialist Trial Supply Operations I-200-21041-067978 | Bioverativ Therapeutics, Inc. | 11-9199.04 Supply Chain Managers | FY2021 Q2 | Waltham, MA, 02451 | $118,000 to $153,400 year | $1,367 | - | sr_dol_oflc_lca_2021_q2_row_074327 |
| Senior Specialist Trial Supply Operations I-200-21041-067978 | Bioverativ Therapeutics, Inc. | 11-9199.04 Supply Chain Managers | FY2021 Q3 | Waltham, MA, 2451 | $118,000 to $153,400 year | $1,367 | - | sr_dol_oflc_lca_2021_q3_row_133918 |
| Senior Associate, Statistical Programming I-200-20346-954124 | Bioverativ Therapeutics, Inc. | 15-2041 Statisticians | FY2021 Q1 | Waltham, MA, 2451 | $116,896 to $127,500 year | $39,312 | - | sr_dol_oflc_lca_2021_q1_row_060316 |
| Senior Associate, Statistical Programming I-200-20328-924657 | Bioverativ Therapeutics, Inc. | 15-2041 Statisticians | FY2021 Q1 | Waltham, MA, 2451 | $116,896 to $127,500 year | $0 | - | sr_dol_oflc_lca_2021_q1_row_044514 |
| Senior Associate, Statistical Programming I-200-20328-924657 | Bioverativ Therapeutics, Inc. | 15-2041.00 Statisticians | FY2021 Q3 | Waltham, MA, 2451 | $116,896 to $127,500 year | $0 | - | sr_dol_oflc_lca_2021_q3_row_049047 |
| Senior Associate, Statistical Programming I-200-20328-924657 | Bioverativ Therapeutics, Inc. | 15-2041.00 Statisticians | FY2021 Q2 | Waltham, MA, 02451 | $116,896 to $127,500 year | $0 | - | sr_dol_oflc_lca_2021_q2_row_157350 |
| Regulatory Operations Lead I-200-20227-770599 | Bioverativ Therapeutics, Inc. | 13-1041.07 Regulatory Affairs Specialists | FY2020 Q4 | Cambridge, MA, 02142 | $100,880 to $165,000 year | $0 | - | sr_dol_oflc_lca_2020_q4_row_062100 |
| Quality Manager Drug Substance Oversight I-200-20169-659891 | Bioverativ Therapeutics, Inc. | 13-1041.00 Compliance Officers | FY2020 Q3 | Waltham, MA, 2451 | $100,000 to $169,000 year | $264 | - | sr_dol_oflc_lca_2020_q3_row_178483 |
| Associate Director Regulatory CMC I-200-20107-492785 | Bioverativ Therapeutics, Inc. | 11-9199.01 Regulatory Affairs Managers | FY2020 Q3 | Waltham, MA, 2451 | $159,744 to $221,000 year | $0 | - | sr_dol_oflc_lca_2020_q3_row_047242 |
| Scientist I-200-20107-494068 | Bioverativ Therapeutics, Inc. | 19-1021.00 Biochemists and Biophysicists | FY2020 Q3 | Waltham, MA, 2451 | $82,930 to $132,500 year | $0 | - | sr_dol_oflc_lca_2020_q3_row_048198 |
| Senior Associate Scientist I-200-20094-456861 | Bioverativ Therapeutics, Inc. | 19-1021.00 Biochemists and Biophysicists | FY2020 Q3 | Waltham, MA, 2451 | $82,930 to $117,000 year | $0 | - | sr_dol_oflc_lca_2020_q3_row_018235 |
| IT Lead I-200-20092-452487 | Bioverativ Therapeutics, Inc. | 15-1121.00 Computer Systems Analysts | FY2020 Q3 | Waltham, MA, 2451 | $125,000 to $160,000 year | $14,531 | - | sr_dol_oflc_lca_2020_q3_row_015426 |
| Global Study Manager I-200-20085-435212 | Bioverativ Therapeutics, Inc. | 15-2041.02 Clinical Data Managers | FY2020 Q3 | Waltham, MA, 2451 | $132,454 to $165,000 year | $0 | - | sr_dol_oflc_lca_2020_q3_row_001720 |
| Scientist, Gene Therapy I-200-20066-386317 | Bioverativ Therapeutics, Inc. | 19-1042.00 Medical Scientists, Except Epidemiologists | FY2020 Q2 | Waltham, MA, 2451 | $82,500 to $160,000 year | $11,530 | - | sr_dol_oflc_lca_2020_q2_row_120355 |
| Master Data Management (MDM) Systems Analyst I-200-20057-353472 | Bioverativ Therapeutics, Inc. | 15-2031.00 Operations Research Analysts | FY2020 Q2 | Waltham, MA, 2451 | $54,163 to $78,000 year | $0 | - | sr_dol_oflc_lca_2020_q2_row_094161 |
| Associate Scientist, Rare Blood Disorders I-200-20052-340808 | Bioverativ Therapeutics, Inc. | 19-1021.00 Biochemists and Biophysicists | FY2020 Q2 | Waltham, MA, 2451 | $60,466 to $107,500 year | $0 | - | sr_dol_oflc_lca_2020_q2_row_084287 |
| Senior Associate Scientist I-200-19350-200004 | Bioverativ Therapeutics, Inc. | 19-1021.00 Biochemists and Biophysicists | FY2020 Q1 | Waltham, MA, 02451 | $60,900 to $113,000 year | $434 | - | sr_dol_oflc_lca_2020_q1_row_102548 |
| Associate Scientist, Complement Research I-200-19305-122996 | Bioverativ Therapeutics, Inc. | 19-1021.00 Biochemists and Biophysicists | FY2020 Q1 | Waltham, MA, 02451 | $82,930 to $113,100 year | $0 | - | sr_dol_oflc_lca_2020_q1_row_050456 |
| Associate Scientist I-200-19298-109045 | Bioverativ Therapeutics, Inc. | 19-1021.00 Biochemists and Biophysicists | FY2020 Q1 | Waltham, MA, 02451 | $82,930 to $113,100 year | $0 | - | sr_dol_oflc_lca_2020_q1_row_041254 |
| Associate Scientist III, Sickle Cell & Immunology I-200-19295-101604 | Bioverativ Therapeutics, Inc. | 19-1021.00 Biochemists and Biophysicists | FY2020 Q1 | Waltham, MA, 02451 | $82,930 to $113,100 year | $0 | - | sr_dol_oflc_lca_2020_q1_row_035737 |
| SENIOR ASSOCIATE SCIENTIST I-200-19253-427714 | Bioverativ Therapeutics, Inc. | 19-1042 MEDICAL SCIENTISTS, EXCEPT EPIDEMIOLOGISTS | FY2019 Q2 | Waltham, MA, 2451 | $70,970 to $113,100 year | $0 | - | sr_dol_oflc_lca_2019_q2_row_603990 |
| ASSOCIATE SCIENTIST III, HEMOGLOBINOPATHIES I-200-19241-125502 | Bioverativ Therapeutics, Inc. | 19-1021 BIOCHEMISTS AND BIOPHYSICISTS | FY2019 Q2 | Waltham, MA, 2451 | $60,900 to $113,100 year | $434 | - | sr_dol_oflc_lca_2019_q2_row_593326 |
| MANAGER, RBD GLOBAL MEDICAL COMMUNICATIONS I-202-19221-533722 | Bioverativ Therapeutics, Inc. | 19-1042 MEDICAL SCIENTISTS, EXCEPT EPIDEMIOLOGISTS | FY2019 Q2 | Cambridge, MA, 2142 | $102,900 to $191,000 year | $10,548 | - | sr_dol_oflc_lca_2019_q2_row_603552 |
| SENIOR ASSOCIATE COMPLIANCE I-200-19081-662187 | Bioverativ Therapeutics, Inc. | 13-1041 COMPLIANCE OFFICERS | FY2019 Q2 | Waltham, MA, 2451 | $72,446 to $98,800 year | $0 | - | sr_dol_oflc_lca_2019_q2_row_027512 |
| PRINCIPAL SCIENTIST FOR GENE THERAPY I-200-19076-053423 | Bioverativ Therapeutics, Inc. | 17-2199 ENGINEERS, ALL OTHER | FY2019 Q2 | Waltham, MA, 2451 | $124,904 to $156,000 year | $0 | - | sr_dol_oflc_lca_2019_q2_row_586285 |
| CLINICAL PHARMACOLOGY LEAD I-200-19079-806675 | Bioverativ Therapeutics, Inc. | 19-1042 MEDICAL SCIENTISTS, EXCEPT EPIDEMIOLOGISTS | FY2019 Q2 | Waltham, MA, 2451 | $102,900 to $191,000 year | $14,354 | - | sr_dol_oflc_lca_2019_q2_row_601494 |
| SCIENTIST I, HEMOGLOBINOPATHIES I-200-19079-634674 | Bioverativ Therapeutics, Inc. | 19-1042 MEDICAL SCIENTISTS, EXCEPT EPIDEMIOLOGISTS | FY2019 Q2 | Waltham, MA, 2451 | $68,786 to $127,500 year | $0 | - | sr_dol_oflc_lca_2019_q2_row_601495 |
| MASTER DATA MANAGEMENT (MDM) SYSTEMS ANALYST I-200-19076-775104 | Bioverativ Therapeutics, Inc. | 15-2031 OPERATIONS RESEARCH ANALYSTS | FY2019 Q2 | Waltham, MA, 2451 | $57,221 to $78,000 year | $0 | - | sr_dol_oflc_lca_2019_q2_row_522352 |
Frequently asked questions
- What are the offered H-1B wages for Bioverativ Therapeutics Inc H-1B wage rows?
- Offered wages among the returned Bioverativ Therapeutics Inc H-1B wage rows rows range from $54,163 to $221,000 in DOL LCA filings. LCA filings are labor-condition applications certified by the U.S. Department of Labor, not active job postings or approved USCIS H-1B petitions.
Get this page with API
Rendered from the bluedoor H-1B Jobs API. Reproduce it:
GET https://api.bluedoor.sh/h1b-jobs/v1/wages?limit=50&company=bioverativ+therapeutics+incJSON